Second Quarter Results Presentation
Filed with ASX · · 42 pages · English
This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forwa
In the deck
Story so far
Earlier from Mesoblast
- Ulcerative Colitis & Crohns Results Presented at ECCO
- Appendix 4C Quarterly Activity Report
- FDAs OTAT Agrees to Primary Endpoint for Back Pain
- Update on Novartis Agreement
- MSB and Oaktree Conclude Refinancing of Senior Debt Facility
Later from Mesoblast
- S&P DJI Announces March 2022 Quarterly Rebalance
- MSB Q3 Financial Results and Operational Highlights
- Third Quarter Results Presentation
- Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
- Reinstatement to Quotation
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast